Cart
sales@molnova.com
Citronellal
CAS No. 106-23-0
Citronellal( (±)-Citronellal )
Catalog No. M21327 CAS No. 106-23-0
Citronellal is a monoterpene predominantly formed by the secondary metabolism of plants producing antithrombotic antiplatelet and antihypertensive activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 28 | In Stock |
|
Biological Information
-
Product NameCitronellal
-
NoteResearch use only, not for human use.
-
Brief DescriptionCitronellal is a monoterpene predominantly formed by the secondary metabolism of plants producing antithrombotic antiplatelet and antihypertensive activities.
-
DescriptionCitronellal is a monoterpene predominantly formed by the secondary metabolism of plants producing antithrombotic antiplatelet and antihypertensive activities.
-
In Vitro——
-
In Vivo——
-
Synonyms(±)-Citronellal
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number106-23-0
-
Formula Weight154.25
-
Molecular FormulaC10H18O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (648.30 mM)
-
SMILESCC(CCC=C(C)C)CC=O
-
Chemical Name6-Octenal 37-dimethyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lu J X Guo C Ou W S et al. Citronellal prevents endothelial dysfunction and atherosclerosis in rats[J]. Journal of Cellular Biochemistry 2018.
molnova catalog
related products
-
Dehydrocorydalin
Dehydrocorydaline exerts anti-metastatic potential via suppression of MMPs and Bcl-2 signaling in NSCLC cells.
-
GSK-3 inhibitor 3
GSK-3 inhibitor 3 is a selective, orally active, brain-permeable GSK-3 inhibitor that inhibits GSK-3α and GSK-3β with IC50s of 0.35 nM and 0.25 nM, respectively.
-
2',5'-Dideoxyadenosi...
2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site (IC50: 3 μM).2',5'-Dideoxyadenosine (20-150 mM), like adenosine, dependently and reversibly inhibits the positive inotropic and chronotropic effect of beta-adrenergic stimulation with isoproterenol (8-54 pmol) up to 70% and 50%, respectively.
